Baidu
map

美国新冠疫苗不良反应达到400000例,FDA在辉瑞和Moderna疫苗说明书中添加心脏炎症警告

2021-07-04 DY MedSci原创

美国所有年龄组在接种疫苗后的不良事件总例数超过400000例。

7月2日,美国CDC更新新冠疫苗接种数据,显示从2020年12月14日至2021年6月25日期间,共有441931份关于所有年龄组接种疫苗的不良事件报告,其中有6985人死亡(比前一周增加了872人)和34065人重症(比前一周增加了2825人)。数据源自疫苗不良事件报告系统 (VAERS) 报告。

截至6月25日,美国 已接种3.212亿剂新冠疫苗。其中包括:1.32亿剂 Moderna 疫苗、1.77亿剂辉瑞疫苗和1200万剂强生(J&J)疫苗。

在截至 6 月 25 日报告的6985例死亡患者中 ,22%发生在接种疫苗后48小时内,15%发生在24小时内,38%发生在接种疫苗后48小时内发病的人中。

上周所有年龄组的数据显示:

  • 21%的死亡与心脏疾病有关。
  • 51%的死亡者为男性,45%为女性,其余的死亡报告未公布死者性别。
  • 平均死亡年龄为74.3岁。
  • 截至6月18日,有2337名孕妇报告了与新冠疫苗有关的不良事件,包括791份流产或早产报告。
  • 在报告的3985例Bell’s麻痹中,55%归因于辉瑞疫苗,42%归因于Moderna疫苗,7%归因于强生疫苗。
  • 在365份吉兰巴雷综合征报告中,45%的病例归因于辉瑞,42%归因于Moderna,19%归因于强生。
  • 过敏性休克报告多达114113份,其中44%的病例归因于辉瑞疫苗,48%归因于Moderna,8%归因于强生。
  • 有7263份凝血功能障碍的报告,其中3151份归因于辉瑞,2566份归因于Moderna,1501份报告归因于强生。
  • 1576例心肌炎和心包炎报告,其中1001例归因于辉瑞,523例归因于Moderna,48例归因于强生。

6 月 25 日,美国FDA曾在辉瑞和Moderna新冠疫苗的患者和提供者情况说明书中添加了警告,表明注射疫苗会增加心肌炎和心包炎风险,特别是会在注射第二剂之后和发病时接种疫苗后几天内出现症状。

FDA的更新是在6月23日疾病预防控制中心免疫实践咨询委员会会议上对信息进行审查和讨论之后进行的,该委员会确认了1200例16至24岁的心肌炎和心包炎病例。

而最近也有两项新研究表明新冠疫苗与心脏炎症之间存在联系。

在6月29日发表于JAMA Cardiology上的一项报告中, 23名 中位年龄为25岁的男性军人在 2021年1月至2021年4 月期间接受了mRNA疫苗接种后的急性胸痛评估。这些人此前没有任何已知的心脏病史或者显著的心脏危险因素及心脏毒性物质暴露史。

在报告中,7名 军人接种了 疫苗,16名军人接种了 Moderna 疫苗。总共20名患者在适当间隔的2 剂系列疫苗的第二剂后出现症状。所有患者的心肌肌钙蛋白水平均显着升高。在疾病急性期接受心脏磁共振成像的8名患者中,所有患者的影响结果均与心肌炎的临床诊断一致。其他检测未发现心肌炎的其他病因,包括急性新冠感染和其他感染、缺血性损伤或潜在的自身免疫性疾病。所有患者都接受了短暂的支持性护理,并且在研究发布时已康复或正在康复。

23 名军事卫生系统心肌炎患者接种新冠疫苗后的人口统计学和临床特征,2021年1月至4月

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.doi:10.1001/jamacardio.2021.2833

在此期间,美国军方接种了超过280 万剂mRNA疫苗。虽然观察到的心肌炎病例数很少,但在第二次接种疫苗后,男性军人的病例数高于预期。

研究人员表示,虽然目前尚不清楚心肌炎的真实发病率,但其表现模式和临床病程表明与疫苗接种的炎症反应有关。

同时,6 月 29 日发表在JAMA Cardiology上的另 一项研究调查了2月1日至4月30日期间的7例急性心肌炎患者情况,其中有4例发生在接受第二剂mRNA疫苗的5天内。

doi:10.1001/jamacardio.2021.2828

研究人员写道:“这4例急性心肌炎病例可能代表了与 mRNA疫苗接种相关的罕见潜在不良事件。该研究结果提示了mRNA新冠疫苗接种与急性心肌炎之间可能存在关联”。

这些研究结论提示我们,对新冠疫苗接种后罕见的不良事件(包括心肌炎)保持警惕是有必要的。但相关研究人员及美国卫生官员都认为,接种新冠疫苗的好处仍然大于任何风险,目前不应降低当前大流行期间对疫苗接种的总体信心。

未来对于疫苗接种相关不良反应我们还将持续记录和探究。

参考文献:

1.Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.doi:10.1001/jamacardio.2021.2833

2. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.doi:10.1001/jamacardio.2021.2828

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2008789, encodeId=27de2008e89b2, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon May 02 04:03:04 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840631, encodeId=e55e1840631d0, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Jun 06 20:03:04 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947400, encodeId=b862194e40037, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Sep 26 04:03:04 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045300, encodeId=fba4204530028, content=<a href='/topic/show?id=9f6de05328a' target=_blank style='color:#2F92EE;'>#疫苗说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70532, encryptionId=9f6de05328a, topicName=疫苗说明书)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Feb 02 07:03:04 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507218, encodeId=4e47150e2187b, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Tue Jul 06 13:03:04 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029693, encodeId=485a1029693fc, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jul 05 01:03:04 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996223, encodeId=551f99622370, content=<a href='/topic/show?id=4dbd580630b' target=_blank style='color:#2F92EE;'>#新冠疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58063, encryptionId=4dbd580630b, topicName=新冠疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jul 04 22:22:26 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2022-05-02 般若傻瓜
  2. [GetPortalCommentsPageByObjectIdResponse(id=2008789, encodeId=27de2008e89b2, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon May 02 04:03:04 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840631, encodeId=e55e1840631d0, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Jun 06 20:03:04 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947400, encodeId=b862194e40037, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Sep 26 04:03:04 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045300, encodeId=fba4204530028, content=<a href='/topic/show?id=9f6de05328a' target=_blank style='color:#2F92EE;'>#疫苗说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70532, encryptionId=9f6de05328a, topicName=疫苗说明书)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Feb 02 07:03:04 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507218, encodeId=4e47150e2187b, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Tue Jul 06 13:03:04 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029693, encodeId=485a1029693fc, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jul 05 01:03:04 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996223, encodeId=551f99622370, content=<a href='/topic/show?id=4dbd580630b' target=_blank style='color:#2F92EE;'>#新冠疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58063, encryptionId=4dbd580630b, topicName=新冠疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jul 04 22:22:26 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2008789, encodeId=27de2008e89b2, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon May 02 04:03:04 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840631, encodeId=e55e1840631d0, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Jun 06 20:03:04 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947400, encodeId=b862194e40037, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Sep 26 04:03:04 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045300, encodeId=fba4204530028, content=<a href='/topic/show?id=9f6de05328a' target=_blank style='color:#2F92EE;'>#疫苗说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70532, encryptionId=9f6de05328a, topicName=疫苗说明书)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Feb 02 07:03:04 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507218, encodeId=4e47150e2187b, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Tue Jul 06 13:03:04 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029693, encodeId=485a1029693fc, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jul 05 01:03:04 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996223, encodeId=551f99622370, content=<a href='/topic/show?id=4dbd580630b' target=_blank style='color:#2F92EE;'>#新冠疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58063, encryptionId=4dbd580630b, topicName=新冠疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jul 04 22:22:26 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2008789, encodeId=27de2008e89b2, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon May 02 04:03:04 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840631, encodeId=e55e1840631d0, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Jun 06 20:03:04 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947400, encodeId=b862194e40037, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Sep 26 04:03:04 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045300, encodeId=fba4204530028, content=<a href='/topic/show?id=9f6de05328a' target=_blank style='color:#2F92EE;'>#疫苗说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70532, encryptionId=9f6de05328a, topicName=疫苗说明书)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Feb 02 07:03:04 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507218, encodeId=4e47150e2187b, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Tue Jul 06 13:03:04 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029693, encodeId=485a1029693fc, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jul 05 01:03:04 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996223, encodeId=551f99622370, content=<a href='/topic/show?id=4dbd580630b' target=_blank style='color:#2F92EE;'>#新冠疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58063, encryptionId=4dbd580630b, topicName=新冠疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jul 04 22:22:26 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2008789, encodeId=27de2008e89b2, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon May 02 04:03:04 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840631, encodeId=e55e1840631d0, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Jun 06 20:03:04 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947400, encodeId=b862194e40037, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Sep 26 04:03:04 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045300, encodeId=fba4204530028, content=<a href='/topic/show?id=9f6de05328a' target=_blank style='color:#2F92EE;'>#疫苗说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70532, encryptionId=9f6de05328a, topicName=疫苗说明书)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Feb 02 07:03:04 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507218, encodeId=4e47150e2187b, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Tue Jul 06 13:03:04 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029693, encodeId=485a1029693fc, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jul 05 01:03:04 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996223, encodeId=551f99622370, content=<a href='/topic/show?id=4dbd580630b' target=_blank style='color:#2F92EE;'>#新冠疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58063, encryptionId=4dbd580630b, topicName=新冠疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jul 04 22:22:26 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2008789, encodeId=27de2008e89b2, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon May 02 04:03:04 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840631, encodeId=e55e1840631d0, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Jun 06 20:03:04 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947400, encodeId=b862194e40037, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Sep 26 04:03:04 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045300, encodeId=fba4204530028, content=<a href='/topic/show?id=9f6de05328a' target=_blank style='color:#2F92EE;'>#疫苗说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70532, encryptionId=9f6de05328a, topicName=疫苗说明书)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Feb 02 07:03:04 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507218, encodeId=4e47150e2187b, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Tue Jul 06 13:03:04 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029693, encodeId=485a1029693fc, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jul 05 01:03:04 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996223, encodeId=551f99622370, content=<a href='/topic/show?id=4dbd580630b' target=_blank style='color:#2F92EE;'>#新冠疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58063, encryptionId=4dbd580630b, topicName=新冠疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jul 04 22:22:26 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-05 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2008789, encodeId=27de2008e89b2, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Mon May 02 04:03:04 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840631, encodeId=e55e1840631d0, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Jun 06 20:03:04 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947400, encodeId=b862194e40037, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sun Sep 26 04:03:04 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045300, encodeId=fba4204530028, content=<a href='/topic/show?id=9f6de05328a' target=_blank style='color:#2F92EE;'>#疫苗说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70532, encryptionId=9f6de05328a, topicName=疫苗说明书)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Feb 02 07:03:04 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507218, encodeId=4e47150e2187b, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Tue Jul 06 13:03:04 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029693, encodeId=485a1029693fc, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jul 05 01:03:04 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996223, encodeId=551f99622370, content=<a href='/topic/show?id=4dbd580630b' target=_blank style='color:#2F92EE;'>#新冠疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58063, encryptionId=4dbd580630b, topicName=新冠疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Jul 04 22:22:26 CST 2021, time=2021-07-04, status=1, ipAttribution=)]

相关资讯

目前监测到的新冠疫苗接种不良反应有哪些?专家回应

目前新冠疫苗接种后监测到的不良反应有哪些?在国务院联防联控机制21日举行的发布会上,中国疾控中心免疫规划首席专家王华庆对此进行了回应。

重要通知发布,影响所有医药人

最新报告出炉,这些药不良反应占比高。

预防抗真菌药物不良反应,这样做就对了!

近年来,真菌逐渐成为引起人类感染的常见病原体之一,但随着抗真菌药的应用,其不良反应的报道逐渐增多,因此我们有必要认识了解抗真菌药物的不良反应,从而预防此类药物不良反应的发生。

国产新冠疫苗:已有数十万人紧急接种,零感染,无一例明显不良反应

昨日(9月11日),“国产新冠灭活疫苗已紧急接种数十万人”的消息引发公众关注。

BMJ:8个国家超1亿人群数据汇总,探讨新冠疫苗接种后不良事件

不同年龄组和性别的AESIs的观察率存在很大差异,这表明在使用背景率进行安全监测之前,需要进行分层或标准化。

2021年卡介苗不良反应临床处理指南

卡介苗(BCG)是一种预防结核病的减毒活疫苗,是至今全球接种最广泛、最安全的疫苗之一。中国自1978年开始广泛接种 BCG后,儿童粟粒性结核病及结核性脑膜炎的发病率和死亡率显著降低。

拓展阅读

接种217针新冠疫苗,身体会发生什么?柳叶刀:全球接种最多的“狂人”,免疫系统竟一切正常!

The Lancet Infectious Diseases:在整个过度接种的过程中,这位大爷(下文被称为HIM)没有报告任何与接种疫苗相关的副作用,62项常规临床化学指标均未出现异常。

厦门大学韩家淮院士团队:为什么新冠疫苗的保护时间如此之短?——有关 COVID-19 疫苗的现状及未来

在这篇研究热点中,厦门大学生命科学学院韩家淮团队分析相关数据,提出新冠疫苗保护率下降迅速与新冠病毒本身性质密切相关。

高福院士团队最新:动态清零结束后,长新冠的发生率近50%,疫苗或改变现状

Emerging Microbes & Infection随着接种疫苗的剂量增加,保护作用也会有所增强;其中,接种4-5针新冠疫苗,表现出最强的保护作用,高烧、寒战、腹泻以及一些中长期症状会显著减少。

上海最近“阳”的人又多了?警惕诱发这种病!

最近这段时间,除了35℃+炙烤大地,上海曜影医院24小时应急门诊,每天都会遇到好几例“阳”:

上海交大李青峰/复旦张文宏合作《STTT》:I型神经纤维瘤病患者接种新冠疫苗后呈现高水平免疫反应

开展相关研究以评价NF1患者接种新冠疫苗的安全性和有效性,具有重要的临床和社会意义。

Lancet:好消息!朱凤才/王忠芳发现mRNA新冠疫苗​异源加强接种安全有效

mRNA异源增强方案中SARS-CoV-2特异性中和抗体应答的血清转化率远高于BBIBP-CorV同源增强方案。

Baidu
map
Baidu
map
Baidu
map